Clinical Trial Update: BXQ-350 Pharmacokinetic/Pharmacodynamic Study in Cancer Patients [EARLY_Phase 1]

View source ↗

Summary

The document reports completion of an early-phase PK/PD study of BXQ-350 in cancer patients. The study focused on peripheral neuropathy and chemotherapy-induced…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Peripheral Neuropathy
• Peripheral Neuropathy

Drugs mentioned

• BXQ-350

Snippet

Sponsor: Bexion Pharmaceuticals, Inc. | Conditions: Neuropathy;Peripheral, Chemotherapy-induced Peripheral Neuropathy | EARLY_Phase 1 | Status: COMPLETED